Clinical Trial Update: Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS)

View source ↗

Summary

The VEGF-focused clinical trial in adult acute lung injury and acute respiratory distress syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Respiratory Distress Syndrome, Adult | Status: WITHDRAWN